Skip to Content
Merck
CN
  • GSTT1 gene abnormality in minimal change nephrotic syndrome with elevated serum immunoglobulin E.

GSTT1 gene abnormality in minimal change nephrotic syndrome with elevated serum immunoglobulin E.

Clinical nephrology (2012-03-27)
Kohei Miyazaki, Keisuke Sugimoto, Shoji Tsuji, Anna Iharada, Shinsuke Fujita, Hidehiko Yanagida, Naoki Sakata, Mitsuru Okada, Kazunari Kaneko, Tsukasa Takemura
ABSTRACT

Imbalance between T-helper 1 (Th1) and 2 (Th2) lymphocytes and effects of reactive oxygen species (ROS) upon glomerular capillary walls have been implicated in minimal change nephrotic syndrome (MCNS). By polymerase chain reaction and comparative genomic hybridization, we evaluated mutations of the GSTT1 gene (GSTT1), a member of the glutathione S-transferase (GST) supergene family associated with both protection of cells from ROS and control of allergic reactions and serum immunoglobulin (Ig) E. Among 15 children with MCNS, IgE elevation (over 2,000 IU/l) and GSTT1 deletion was found in 2 who showed severe allergic symptoms. Serum ROS concentrations in these 2 patients were significantly higher than in healthy controls or other MCNS patients. In addition, a Th2 shift caused by increased serum interleukin (IL)- 4 was observed. These results suggest presence of a GSTT1 abnormality in some children with MCNS having marked serum IgE elevations and various allergic complications. Defective ROS degradation and Th1/Th2 imbalance caused by GSTT1 abnormality could initiate proteinuria leading to MCNS.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Mizoribine, ≥98% (TLC)